Jacinto Sarmentero

815 total citations
15 papers, 660 citations indexed

About

Jacinto Sarmentero is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jacinto Sarmentero has authored 15 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Jacinto Sarmentero's work include Cancer, Hypoxia, and Metabolism (5 papers), Protein Degradation and Inhibitors (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Jacinto Sarmentero is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Protein Degradation and Inhibitors (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Jacinto Sarmentero collaborates with scholars based in Spain, United States and Poland. Jacinto Sarmentero's co-authors include Juan Carlos Lacal, Ana Ramı́rez de Molina, David Gallego‐Ortega, María J. Barrero, Verónica García-Carpizo, Sergio Ruiz‐Llorente, Mónica Báñez-Coronel, Miguel Ángel García‐Cabezas, Paloma Cejas and Fátima Valdés‐Mora and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Jacinto Sarmentero

14 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacinto Sarmentero Spain 12 392 229 173 77 75 15 660
Laoighse Mulrane Ireland 9 501 1.3× 351 1.5× 142 0.8× 44 0.6× 94 1.3× 15 777
Lee Lee Wong Singapore 11 441 1.1× 246 1.1× 90 0.5× 45 0.6× 51 0.7× 17 644
Dao-Hai Zhang Singapore 6 344 0.9× 174 0.8× 179 1.0× 56 0.7× 50 0.7× 7 535
Nobuyasu Yoshimoto Japan 15 381 1.0× 348 1.5× 220 1.3× 23 0.3× 74 1.0× 30 741
Shushu Wang China 15 258 0.7× 118 0.5× 106 0.6× 31 0.4× 52 0.7× 37 536
Xuelian Ren China 11 539 1.4× 252 1.1× 116 0.7× 40 0.5× 66 0.9× 37 790
Dimitra Tsavachidou United States 10 395 1.0× 241 1.1× 180 1.0× 62 0.8× 203 2.7× 15 703
Kyoko Iwao‐Koizumi Japan 9 385 1.0× 213 0.9× 142 0.8× 30 0.4× 54 0.7× 16 608
Angela Eldridge United States 7 379 1.0× 151 0.7× 212 1.2× 49 0.6× 65 0.9× 8 621
Masaru Ushijima Japan 17 596 1.5× 490 2.1× 233 1.3× 52 0.7× 116 1.5× 38 1.0k

Countries citing papers authored by Jacinto Sarmentero

Since Specialization
Citations

This map shows the geographic impact of Jacinto Sarmentero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacinto Sarmentero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacinto Sarmentero more than expected).

Fields of papers citing papers by Jacinto Sarmentero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacinto Sarmentero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacinto Sarmentero. The network helps show where Jacinto Sarmentero may publish in the future.

Co-authorship network of co-authors of Jacinto Sarmentero

This figure shows the co-authorship network connecting the top 25 collaborators of Jacinto Sarmentero. A scholar is included among the top collaborators of Jacinto Sarmentero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacinto Sarmentero. Jacinto Sarmentero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sarmentero, Jacinto, María Cámara, Javier Salamanca, et al.. (2025). Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer. British Journal of Cancer. 133(3). 404–419. 1 indexed citations
2.
3.
Soldevilla, Beatriz, Ángeles López‐Gonzálvez, Anna La Salvia, et al.. (2021). Comprehensive Plasma Metabolomic Profile of Patients with Advanced Neuroendocrine Tumors (NETs). Diagnostic and Biological Relevance. Cancers. 13(11). 2634–2634. 16 indexed citations
4.
García-Carpizo, Verónica, Sergio Ruiz‐Llorente, Jacinto Sarmentero, Ana González‐Corpas, & María J. Barrero. (2019). CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines. Molecular Cancer Research. 17(3). 720–730. 28 indexed citations
5.
Soldevilla, Beatriz, Gonzalo Goméz-López, Fátima Al‐Shahrour, et al.. (2019). The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications. European Journal of Cancer. 123. 118–129. 59 indexed citations
6.
García-Carpizo, Verónica, Sergio Ruiz‐Llorente, Jacinto Sarmentero, et al.. (2018). CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation. Epigenetics & Chromatin. 11(1). 30–30. 44 indexed citations
7.
García-Carpizo, Verónica, Jacinto Sarmentero, Bomie Han, et al.. (2016). NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation. Scientific Reports. 6(1). 32952–32952. 42 indexed citations
8.
Hernando, Eva, Jacinto Sarmentero, Theresa M. Koppie, et al.. (2009). A critical role for choline kinase-α in the aggressiveness of bladder carcinomas. Oncogene. 28(26). 2425–2435. 51 indexed citations
9.
Gallego‐Ortega, David, Ana Ramı́rez de Molina, Fátima Valdés‐Mora, et al.. (2009). Differential Role of Human Choline Kinase α and β Enzymes in Lipid Metabolism: Implications in Cancer Onset and Treatment. PLoS ONE. 4(11). e7819–e7819. 86 indexed citations
10.
Molina, Ana Ramı́rez de, David Gallego‐Ortega, Jacinto Sarmentero, et al.. (2008). Choline kinase as a link connecting phospholipid metabolism and cell cycle regulation: Implications in cancer therapy. The International Journal of Biochemistry & Cell Biology. 40(9). 1753–1763. 67 indexed citations
11.
Báñez-Coronel, Mónica, et al.. (2008). Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells. Current Cancer Drug Targets. 8(8). 709–719. 48 indexed citations
12.
Gallego‐Ortega, David, et al.. (2008). Differential role of choline kinase alpha and beta isoforms in human carcinogenesis. European Journal of Cancer Supplements. 6(9). 26–26. 4 indexed citations
13.
Molina, Ana Ramı́rez de, Jacinto Sarmentero, Cristóbal Belda-Iniesta, et al.. (2007). Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. The Lancet Oncology. 8(10). 889–897. 130 indexed citations
14.
Gallego‐Ortega, David, Ana Ramı́rez de Molina, Ruth Gutiérrez, et al.. (2006). Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer.. PubMed. 29(2). 335–40. 16 indexed citations
15.
Molina, Ana Ramı́rez de, et al.. (2005). Choline Kinase Is a Novel Oncogene that Potentiates RhoA-Induced Carcinogenesis. Cancer Research. 65(13). 5647–5653. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laoighse Mulrane Breakdown of academic impact, for papers by Lee Lee Wong Breakdown of academic impact, for papers by Dao-Hai Zhang Breakdown of academic impact, for papers by Nobuyasu Yoshimoto Breakdown of academic impact, for papers by Shushu Wang Breakdown of academic impact, for papers by Xuelian Ren Breakdown of academic impact, for papers by Dimitra Tsavachidou Breakdown of academic impact, for papers by Kyoko Iwao‐Koizumi Breakdown of academic impact, for papers by Angela Eldridge Breakdown of academic impact, for papers by Masaru Ushijima
Rankless by CCL
2026